TABLE 1.
No. | % | |
---|---|---|
Total | 97 | |
Age | Median 67 (33–68) | |
Sex | ||
Male | 48 | 49 |
Female | 49 | 51 |
Stage | ||
Unknown | 4 | 4 |
IIIB | 61 | 63 |
IIIC | 29 | 30 |
IV | 3 | 3 |
Stage IIIC/IV resected peri-ILI | 10 | 10 |
M-ILI + ADH-1 trial | 22 | 23 |
M-ILI + sorafenib trial | 6 | 6 |
Previous regional chemotherapy | 4 | 4 |